Study of KCC Peptide Application in the Colon
NCT02156557
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Colon Polyps
Colorectal Cancer
Inflammatory Bowel Disease (IBD)
Interventions
BIOLOGICAL:
Colon KCC Heptapeptide
Sponsor
Danielle Kim Turgeon
Collaborators
[object Object]